Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Sihuan Pharma Doubled its Revenue in 2011

publication date: Mar 19, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sihuan Pharma said its revenues  for full-year 2011 were 2.24 billion RMB ($354 million), an increase of 116%, while net income rose 58% to 824 million RMB ($130 million). The company announced numerous acquisitions in 2011, but pharmaceutical products from these acquired companies contributed only about one-third of the increase. Sihuan offered the good news that it was successful at winning additional tenders last year “in most regions and at stable price levels.” More details....

Stock Symbol: (HK: 0460)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...